Skip to main content
. 2023 Dec 20;61(7):4712–4731. doi: 10.1007/s12035-023-03867-x

Table 1.

Main tau fragments involved in tau pathology

Type of fragments Associated proteases Found in CSF Lesion References
TauΔD421 Caspase-3, -6, -7 Reported Axonal loss, mitochondrial dysfunction, tau polymerization, and aggregation in vitro [116119]
ΔTau314 Caspase-2 Not yet reported Mislocalization to dendritic spine, reduction of AMPA receptor, and excitatory neurotransmission [120, 121]
17 kDa tau Calpain-1 and -2 Not yet reported Altering the composition of cytoskeleton, synaptic degeneration through clathrin-mediated pathway, blocking axonal transport [122, 123]
N224 tau Calpain-2 Reported Not clear (but worthy of diagnosis) [124126]
Tau1–368 AEP Reported Promoting aggregation, promoting the expression of Aβ, phosphorylation inducing memory impairment [127130]
Tau168–368 AEP Not yet reported Accumulation in microglial cells [131]
26–230tau (NH2-tau), 26–44 NH2-tau Caspase and calpain-1 and caplain-2 Reported Damage of mitochondrial function, presynaptic defect, damage of study/memory function [110, 132137]
tau151–391, tau297–391 Unknown Not yet reported Form PHFs in vitro and cultured cells [138, 139]